FDA Grants Fast-Track Approval to Ovarian Cancer Drug

Share this content:
FDA Grants Fast-Track Approval to Ovarian Cancer Drug
FDA Grants Fast-Track Approval to Ovarian Cancer Drug

MONDAY, Dec. 19, 2016 (HealthDay News) -- The drug Rubraca (rucaparib) has been granted accelerated approval by the U.S. Food and Drug Administration to treat advanced ovarian cancer.

The approval is limited to cases where the cancer is caused by deleterious BRCA mutations. The FDA simultaneously approved the FoundationFocus CDxBRCA diagnostic screen. This test detects the presence of deleterious BRCA mutations in the tumors of women with ovarian cancer, the FDA said.

Rubraca was evaluated in clinical studies involving 106 women with BRCA-mutated advanced ovarian cancer. Fifty-four percent of participants given Rubraca had a complete or partial shrinkage of tumors, lasting an average of 9.2 months, the agency said.

The most common side effects of the drug included nausea, fatigue, vomiting, anemia, abdominal pain, dysgeusia, and loss of appetite. The drug was also associated with myelodysplastic syndrome, acute myeloid leukemia, and harm to a developing fetus, the FDA warned.

Rubraca is marketed by Boulder, Colo.-based Clovis Oncology.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Doctors Urged to Speak With Patients About Firearms

Doctors Urged to Speak With Patients About Firearms

Making a public commitment is encouraged as a positive action that physicians can take

Machine Learning Model Predicts Risk of Upgrade to Breast CA

Machine Learning Model Predicts Risk of Upgrade to ...

Model can predict risk of upgrade of high-risk breast lesions to cancer using traditional, text features

Glycemic Control Up With Oral Semaglutide in Type 2 Diabetes

Glycemic Control Up With Oral Semaglutide in Type ...

Phase 3 studies next to assess longer-term/clinical outcomes, safety

is free, fast, and customized just for you!

Already a member?

Sign In Now »